Monitoring cardiac function in patients receiving doxorubicin.
about
Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapyEffects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivoIncreased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyTranscriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelEffects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria.Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle.Equilibrium radionuclide angiocardiography: Its usefulness in current practice and potential future applications.Erythropoietin improves the healing of skin necrosis resulting from Doxorubicin extravasation in a rat modelBGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice.Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Biomarkers for monitoring chemotherapy-induced cardiotoxicity.
P2860
Q27027328-45A9AFBB-D1DB-47F6-9D8E-4DDDEEE894B5Q28258783-1FD897FE-0089-48F3-991D-842E9008AF99Q28385656-9DFA5672-9D76-494B-A8AF-30A95E93F24EQ33404672-E4916FB4-6A34-4775-8420-282844EF59A7Q33649513-1D8E55FB-FB2B-4CBB-8606-F22FD18AAD0BQ34357604-7CEB1BAD-BDD6-4EA2-A35C-A72954A45172Q34808155-0E20E088-7955-444A-88CF-0FA39A1B6CBDQ35141318-7BAFF730-1786-4659-A534-4C6B68840F16Q36392616-800C35C8-2D5E-4E56-B47E-DA5E9D0D43CAQ37642505-4AD71A15-BCDA-44AD-B28B-9431B4AF6D41Q37742823-EC5B403C-8B71-490C-84EC-5E316A75A269Q38831900-EEBA9F3A-1E40-440C-89F2-7A75405666B7Q39053477-70975457-11B8-4615-B485-E9FDA6306C03
P2860
Monitoring cardiac function in patients receiving doxorubicin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Monitoring cardiac function in patients receiving doxorubicin.
@ast
Monitoring cardiac function in patients receiving doxorubicin.
@en
type
label
Monitoring cardiac function in patients receiving doxorubicin.
@ast
Monitoring cardiac function in patients receiving doxorubicin.
@en
prefLabel
Monitoring cardiac function in patients receiving doxorubicin.
@ast
Monitoring cardiac function in patients receiving doxorubicin.
@en
P1476
Monitoring cardiac function in patients receiving doxorubicin.
@en
P2093
P304
P356
10.1053/J.SEMNUCLMED.2005.02.005
P577
2005-07-01T00:00:00Z